Congratulations to the following faculty members for receiving these sponsored research awards:
Sponsored Research
Jatin Roper of Gastroenterology has received an award from the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer for a project entitled "Chemoprevention of duodenal and rectal polyposis in familial adenomatous polyposis (FAP) with fish oil." Total funding will be $100,000.
John Strouse of Hematology has received an award from the American Society of Hematology for a project entitled "ASH Research Collaborative� Sickle Cell Disease Research Network." Total funding will be $150,000.
Industry Sponsored Clinical Trials
Terry Fortin of Cardiology has received an award from Merck Sharp & Dohme LLC for a project entitled "SOTERIA Cont MK-7962-038 An Open-label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH (MK-7962-038)." Total funding will be $559,070.
Marat Fudim of Cardiology has received an award from 35Pharma Inc. for a project entitled "DCA08 HS235-003." Total funding will be $540,799.
Michel Khouri of Cardiology has received a sub-award () through Yale University for a project entitled "The Transthyretin Amyloid Cardiomyopathy Early Detection with Artificial Intelligence (TRACE-AI) Network Study." Total funding will be $288,701.
Sudarshan Rajagopal of Cardiology has received an award from Merck Sharp & Dohme LLC for a project entitled "HARMONIZE- A Phase 2, Multicenter, Double-blind, Extension Study to Evaluate the Effects of Sotatercept for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) due to Heart Failure with Preserved Ejection." Total funding will be $260,524.
Nicole Jawitz of Gastroenterology has received an award from Spyre Therapeutics, Inc. for a project entitled "SPY123-201 Phase 2 Platform Trial to Assess the Efficacy and Safety of Long-acting Antibodies as Single Agents and in Combinations for Moderately to Severely Active Ulcerative Colitis." Total funding will be $92,328.
Grace Lee of Hematology has received an award from Gilero, LLC for a project entitled "Leukocyte Removal Efficacy - Gilero." Total funding will be $20,344.
James White of Hematology has received an award from Tesla Biohealing, Inc for a project entitled "Anti aging potential of biophoton therapy." Total funding will be $63,776.
Julia Messina of Infectious Diseases has received an award from Electra Therapeutics for a project entitled "sHLH Natural History." Total funding will be $181,914.
Niharika Mettu of Oncology has received an award from BioNTech SE for a project entitled "A Phase I/II, open-label, adaptive two-part trial to evaluate the safety, efficacy, optimal dose and pharmacokinetics of BNT326 as monotherapy and in combination with cancer immunotherapies in participants with advanced solid tumors.." Total funding will be $642,965.
Aman Opneja of Oncology has received an award from Endevica Bio for a project entitled "Optimizing Body Mass Index (BMI) with TCMCB07 in Patients with Newly Diagnosed Metastatic Colore." Total funding will be $632,537.
Aman Opneja of Oncology has received an award from AstraZeneca UK Limited for a project entitled "Effectiveness of T-DXd across HER2-positive solid tumors in patients who have received prior systemic treatment and have no satisfactory alternative treatment options: A hybrid observational study." Total funding will be $65,826.
John Strickler of Oncology has received an award from AbbVie Inc. for a project entitled "A Global First-in-Human Study in NSCLC, HNSCC, and Solid Tumors with Azirkitug (ABBV�514) as a Single Agent and in Combination with Budigalimab or Bevacizumab." Total funding will be $1,611,504.
Matthew McCravy of Pulmonary has received an award from Connect Biopharm LLC for a project entitled "SEEBREEZE - A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Rademikibart as an Add-on Treatment for Acute Exacerbation in Participants With Chronic Obstructive Pulmonar." Total funding will be $182,830.